Abhishek Sharma

Abhishek Sharma

Active Director Director DIN 07620249
DIN 07620249 First appointment Oct 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value •••• Premium profile

About Abhishek Sharma

Data last updated:

Abhishek Sharma is a Director at Maxicon Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Maxicon Pharmaceuticals Private Limited reported revenue of ₹2.39 Cr (FY 2024).

DIN 07620249
Primary Designation Director
Industry Pharma
First Appointment 27 Oct 2016
Oldest Company Age 11 yrs
Largest company Maxicon Pharmaceuticals Private Limited · ₹2.39 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20162015₹2.39 Cr (FY 2024)Active

Board colleagues of Abhishek Sharma

Directorship timeline

Open interactive timeline →
Maxicon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhishek Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Sharma

Abhishek Sharma currently holds 1 directorship: Maxicon Pharmaceuticals Private Limited (Director, since 27 Oct 2016, revenue ₹2.39 Cr (FY 2024)).

Abhishek Sharma was first appointed on 27 Oct 2016 as Director at Maxicon Pharmaceuticals Private Limited.

The current boards of Abhishek Sharma's companies include Sapna Saini (Maxicon Pharmaceuticals Private Limited), Suresh Chand Saini (Maxicon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available